Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study

Affiliations

• ¹ 2nd Respiratory Department, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
• ² 1st Respiratory Department, Sotiria Chest Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
• ³ 7th Respiratory Clinic, "Sotiria" Chest Hospital, Athens, Greece.
• ⁴ Pulmonary Department, Aristotle University of Thessaloniki, G. Papanikolaou Hospital, Thessaloniki, Greece.
• ⁵ Outpatient Respiratory Clinic, Heraklion, Crete, Greece.
• ⁶ Allergy Unit, 2nd Department of Dermatology and Venereology, Attikon University General Hospital, Athens, Greece.
• ⁷ 5th Respiratory Clinic, "Sotiria" Chest Hospital, Athens, Greece.
• ⁸ Department of Medicine II, Division of Pulmonology, Medical University of Vienna, Vienna, Austria.
• ⁹ Pulmonary Department, 424 Army General Hospital, Thessaloniki, Greece.
• ¹⁰ Respiratory Medicine School of Medicine, University of Crete, Heraklion, Crete, Greece.
• ¹¹ Private Practice, Chania, Greece.
• ¹² Department of Respiratory Medicine, Medical School, Democritus University of Thrace, University General Hospital Dragana, Alexandroupolis, Greece.
• ¹³ 1st Pulmonary Department, Papanikolaou General Hospital Thessaloniki, Thessaloniki, Greece.
• ¹⁴ Private Practice, Kalamata, Greece.
• ¹⁵ Pulmonary Department Corfu General Hospital, Corfu, Greece.
• ¹⁶ Private Practice, Trikala, Greece.
• ¹⁷ GSK Medical Department Greece, Athens, Greece.
• ¹⁸ Respiratory Medicine Department, University of Ioannina Medical School, Ioannina, Greece.